T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
D.R. Horton
DHI
$41.7B
| $15.8M | ﹤0.01% |
578,870
+6,700
| +1% | +$180K |
|
|
BV
1202
DELISTED
Bazaarvoice, Inc.
BV
| $15.8M | ﹤0.01% |
2,682,374
-3,678,474
| -58% | -$21.4M |
|
|
ANTX
1203
DELISTED
Anthem, Inc.
ANTX
| $15.7M | ﹤0.01% |
+300,000
| New | +$16M |
|
1204
Zions Bancorporation
ZION
$10.5B
| $15.7M | ﹤0.01% |
494,091
-1,180,270
| -70% | -$34.7M |
|
|
SIX
1205
DELISTED
Six Flags Entertainment Corp.
SIX
| $15.6M | ﹤0.01% |
348,800
-5,700
| -2% | -$273K |
|
1206
Huntington Bancshares
HBAN
$36.1B
| $15.6M | ﹤0.01% |
1,380,895
+45,500
| +3% | +$509K |
|
1207
Huron Consulting
HURN
$2.44B
| $15.6M | ﹤0.01% |
222,784
+13,400
| +6% | +$878K |
|
|
UNVR
1208
DELISTED
Univar Solutions Inc.
UNVR
| $15.6M | ﹤0.01% |
+599,500
| New | +$15.8M |
|
|
CNR
1209
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $15.6M | ﹤0.01% |
1,035,472
-148,500
| -13% | -$2.33M |
|
|
CRZO
1210
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $15.5M | ﹤0.01% |
315,500
+133,600
| +73% | +$6.96M |
|
1211
Skywest
SKYW
$4.16B
| $15.5M | ﹤0.01% |
1,032,460
+3,200
| +0.3% | +$47.8K |
|
|
DXYN
1212
DELISTED
Dixie Group Inc
DXYN
| $15.5M | ﹤0.01% |
1,478,420
+19,600
| +1% | +$198K |
|
1213
BlackRock TCP Capital
TCPC
$342M
| $15.5M | ﹤0.01% |
1,014,105
+29,200
| +3% | +$465K |
|
|
SWN
1214
DELISTED
Southwestern Energy Company
SWN
| $15.5M | ﹤0.01% |
680,705
+8,120
| +1% | +$208K |
|
1215
RenaissanceRe
RNR
$13.4B
| $15.5M | ﹤0.01% |
152,385
+6,130
| +4% | +$632K |
|
|
FPRX
1216
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $15.4M | ﹤0.01% |
620,810
-1,800
| -0.3% | -$40.1K |
|
1217
Capri Holdings
CPRI
$1.76B
| $15.2M | ﹤0.01% |
362,141
+2,889
| +0.8% | +$163K |
|
|
CLNY
1218
DELISTED
Colony Capital, Inc.
CLNY
| $15.2M | ﹤0.01% |
672,440
+2,600
| +0.4% | +$66.1K |
|
|
ARRS
1219
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $15.2M | ﹤0.01% |
497,614
+47,600
| +11% | +$1.54M |
|
1220
Fair Isaac
FICO
$23.6B
| $15.2M | ﹤0.01% |
167,469
+156,600
| +1,441% | +$14M |
|
|
EXAS
1221
DELISTED
Exact Sciences
EXAS
| $15.2M | ﹤0.01% |
511,100
+10,500
| +2% | +$264K |
|
1222
United Rentals
URI
$71.8B
| $15.2M | ﹤0.01% |
173,060
+3,490
| +2% | +$334K |
|
1223
Steel Dynamics
STLD
$37B
| $15.1M | ﹤0.01% |
728,128
-34,500
| -5% | -$743K |
|
|
SHOR
1224
DELISTED
ShoreTel, Inc.
SHOR
| $15.1M | ﹤0.01% |
2,222,152
+5,600
| +0.3% | +$38.9K |
|
1225
Fortune Brands Innovations
FBIN
$5.73B
| $15M | ﹤0.01% |
384,072
-8,365
| -2% | -$327K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.